Keyword: Charles River


Charles River Acquires Explora BioLabs

25.04.2022 -

Charles River Laboratories, a US specialist provider of laboratory, gene and cell therapy services, has acquired Explora BioLabs for approximately $295 million in cash.


Charles River Sells Assets in Sweden and Japan

18.10.2021 -

US-based Charles River Laboratories International on Oct. 12 completed the divestment of its gene therapy CDMO site in Sweden and its research models and services...


Charles River Acquires Vigene Biosciences

26.05.2021 -

US CDMO Charles River Laboratories has entered into an agreement to buy Vigene Biosciences, a compatriot gene therapy CDMO specializing in viral vectors. The acquisition...


Charles River Buys Cognate BioServices

02.03.2021 -

Charles River Laboratories has agreed to buy Cognate BioServices, a cell and gene therapy CDMO, for about $875 million. The purchase is expected to close by the end of...


Takeda and Charles River in Drug Discovery Pact

04.02.2020 - Japanese drugmaker Takeda has entered into a multi-year drug discovery collaboration with contract research organization (CRO) Charles River. The companies, which have a long...

Markets & Companies

ChemSpec Europe 2018: Online Partnering Program Creates Smart Networking Opportunities

28.02.2018 - ChemSpec Europe 2018: The Fine and Specialty Chemicals exhibition, taking place 20 – 21 June 2018 at Koelnmesse in Cologne, Germany, is known for being a key marketplace for...

Chemistry & Life Sciences

Chemspec Europe 2017 in Munich bigger than ever

24.05.2017 - Chemspec Europe 2017 is just around the corner: The 32nd edition of the International Exhibition for Fine and Speciality Chemicals takes place from 31 May – 1 June 2017 at the...

Chemistry & Life Sciences

Chemspec Europe 2017 Show Preview now available

12.05.2017 - Chemspec Europe 2017 is the International Exhibition for Fine and Speciality Chemicals. From 31 May – 1 June 2017, about 390 exhibitors from 29 countries will meet at the Munich...